Case study – MHRA Horizon Scanning Case Study: Developing standards for Adeno-associated virus gene therapies
Horizon scanning at the MHRA leads to external funding being secured, helping our scientists work in a new area of standardisation that will support developers and manufacturers of AAV gene therapies.
Read the full news report here. Published on the 16th of November 2022.
OpenEdition vous propose de citer ce billet de la manière suivante :
adelage (25 janvier 2023). Case study – MHRA Horizon Scanning Case Study: Developing standards for Adeno-associated virus gene therapies. ELSIBI. Consulté le 19 janvier 2025 à l’adresse https://doi.org/10.58079/o66q
